> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA to Study Ad Disclosures
- URL: https://www.fdaweb.com/fda-to-study-ad-disclosures/
- Published: 2018-08-09T12:00:00.000Z
- Updated: 2026-09-15T00:24:50.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5142075

FDA says it wants to do research to determine how useful disclosures regarding prescription drug information are when presented prominently and adjacent to claims in print ads. An 8/9 *Federal Register* [notice](https://www.gpo.gov/fdsys/pkg/FR-2018-08-09/pdf/2018-17045.pdf?ref=fdaweb.com) says the specific question to be examined is whether healthcare professionals and consumers are able to use disclosures to effectively frame information in efficacy claims in prescription drug promotion. The presentations to be researched will cover scope of treatment, ease of use, and statistical significance, the notice says.

The notice also includes comments received by FDA on a 6/14/17 notice seeking public comment on this proposed collection of information, with the agency’s response to the comments.